- Home
- RIO vs BSX Comparison
RIO vs BSX Comparison
Compare RIO & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIO
- BSX
- Stock Information
- Founded
- RIO 1873
- BSX 1979
- Country
- RIO United Kingdom
- BSX United States
- Employees
- RIO N/A
- BSX N/A
- Industry
- RIO Metal Mining
- BSX Medical/Dental Instruments
- Sector
- RIO Basic Materials
- BSX Health Care
- Exchange
- RIO Nasdaq
- BSX Nasdaq
- Market Cap
- RIO N/A
- BSX 138.5B
- IPO Year
- RIO N/A
- BSX 1992
- Fundamental
- Price
- RIO $58.47
- BSX $93.56
- Analyst Decision
- RIO Buy
- BSX Strong Buy
- Analyst Count
- RIO 4
- BSX 23
- Target Price
- RIO $73.00
- BSX $107.61
- AVG Volume (30 Days)
- RIO 3.6M
- BSX 10.0M
- Earning Date
- RIO 02-19-2025
- BSX 04-23-2025
- Dividend Yield
- RIO 6.90%
- BSX N/A
- EPS Growth
- RIO 14.71
- BSX 16.82
- EPS
- RIO 7.07
- BSX 1.25
- Revenue
- RIO $53,658,000,000.00
- BSX $16,747,000,000.00
- Revenue This Year
- RIO $1.59
- BSX $15.60
- Revenue Next Year
- RIO $1.48
- BSX $10.28
- P/E Ratio
- RIO $8.23
- BSX $76.04
- Revenue Growth
- RIO N/A
- BSX 17.61
- 52 Week Low
- RIO $51.67
- BSX $66.80
- 52 Week High
- RIO $74.24
- BSX $107.17
- Technical
- Relative Strength Index (RSI)
- RIO 48.88
- BSX 42.75
- Support Level
- RIO $56.77
- BSX $86.77
- Resistance Level
- RIO $58.71
- BSX $96.69
- Average True Range (ATR)
- RIO 1.62
- BSX 3.98
- MACD
- RIO 0.26
- BSX -0.02
- Stochastic Oscillator
- RIO 77.45
- BSX 49.54
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.